anti-CD22 immunotoxin
Term · Oncology and biomedicine · MLC-T-ONC-000596
A monoclonal antibody linked to a toxic substance. It is being studied in the treatment of some types of B-cell cancer. Anti-CD22 immunotoxin is made in the laboratory. It binds to CD22, a protein on the surface of normal B cells and B-cell tumors, and kills the cells.
| Identifier | MLC-T-ONC-000596 |
|---|---|
| Field | Oncology and biomedicine |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-000596",
"term": "anti-CD22 immunotoxin",
"field": "Oncology and biomedicine",
"definition": "A monoclonal antibody linked to a toxic substance. It is being studied in the treatment of some types of B-cell cancer. Anti-CD22 immunotoxin is made in the laboratory. It binds to CD22, a protein on the surface of normal B cells and B-cell tumors, and kills the cells.",
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/anti-cd22-immunotoxin/"
}
Record 1,395 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.